A G Pinder1, E Pittaway, K Morris, P E James. 1. The Wales Heart Research Institute, Department of Cardiology, Cardiff University School of Medicine, Heath Campus, Cardiff.
Abstract
BACKGROUND AND PURPOSE: It is postulated that nitrite requires reduction to nitric oxide in order to exert its relaxant effect upon isolated hypoxic vessels. Herein, we evaluate the relative contribution of nitric oxide and characterize the downstream mechanisms of nitrite-induced vasorelaxation. EXPERIMENTAL APPROACH: Aortic rings were treated with pharmacological agents and exposed to hypoxia (<1% O(2)). Following pre-constriction, nitrite (10 microM final) was added to appropriate baths; isometric tension was recorded throughout. KEY RESULTS: Nitrite (under hypoxic conditions at physiological pH) is capable of exerting physiological effects that cannot be completely inhibited by the inhibitor of soluble guanylate cyclase (sGC), 1H [1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one or a nitric oxide scavenger (carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide). Simultaneous blockade of both sGC and cyclooxygenase (COX) completely inhibited the response to nitrite. With regard to the nitric oxide-dependent component, we confirm that aldehyde oxidase, but not xanthine oxidase or endothelial nitric oxide synthase, was important for the actions of nitrite in our model. CONCLUSIONS AND IMPLICATIONS: Nitric oxide generated from nitrite is not exclusively responsible for the physiological actions observed in isolated hypoxic vessels. Nitrite operates via different pathways dependent on the presence or absence of endothelium to produce vasorelaxation. In intact vessels, both sGC and COX enzymes appear to be important. Irrespective of this difference in relaxation mechanism, nitrite is capable of producing the same maximum relaxation, regardless of the presence of endothelium. Having investigated possible nitrite reduction sites, we confirm that aldehyde oxidase is important for the actions of nitrite.
BACKGROUND AND PURPOSE: It is postulated that nitrite requires reduction to nitric oxide in order to exert its relaxant effect upon isolated hypoxic vessels. Herein, we evaluate the relative contribution of nitric oxide and characterize the downstream mechanisms of nitrite-induced vasorelaxation. EXPERIMENTAL APPROACH: Aortic rings were treated with pharmacological agents and exposed to hypoxia (<1% O(2)). Following pre-constriction, nitrite (10 microM final) was added to appropriate baths; isometric tension was recorded throughout. KEY RESULTS:Nitrite (under hypoxic conditions at physiological pH) is capable of exerting physiological effects that cannot be completely inhibited by the inhibitor of soluble guanylate cyclase (sGC), 1H [1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one or a nitric oxide scavenger (carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide). Simultaneous blockade of both sGC and cyclooxygenase (COX) completely inhibited the response to nitrite. With regard to the nitric oxide-dependent component, we confirm that aldehyde oxidase, but not xanthine oxidase or endothelial nitric oxide synthase, was important for the actions of nitrite in our model. CONCLUSIONS AND IMPLICATIONS: Nitric oxide generated from nitrite is not exclusively responsible for the physiological actions observed in isolated hypoxic vessels. Nitrite operates via different pathways dependent on the presence or absence of endothelium to produce vasorelaxation. In intact vessels, both sGC and COX enzymes appear to be important. Irrespective of this difference in relaxation mechanism, nitrite is capable of producing the same maximum relaxation, regardless of the presence of endothelium. Having investigated possible nitrite reduction sites, we confirm that aldehyde oxidase is important for the actions of nitrite.
Authors: Benjamin P Luchsinger; Eric N Rich; Yun Yan; Elizabeth M Williams; Jonathan S Stamler; David J Singel Journal: J Inorg Biochem Date: 2005-04 Impact factor: 4.155
Authors: Kenyatta Cosby; Kristine S Partovi; Jack H Crawford; Rakesh P Patel; Christopher D Reiter; Sabrina Martyr; Benjamin K Yang; Myron A Waclawiw; Gloria Zalos; Xiuli Xu; Kris T Huang; Howard Shields; Daniel B Kim-Shapiro; Alan N Schechter; Richard O Cannon; Mark T Gladwin Journal: Nat Med Date: 2003-11-02 Impact factor: 53.440
Authors: Wael F Alzawahra; M A Hassan Talukder; Xiaoping Liu; Alexandre Samouilov; Jay L Zweier Journal: Am J Physiol Heart Circ Physiol Date: 2008-06-06 Impact factor: 4.733
Authors: Martin Feelisch; Bernadette O Fernandez; Nathan S Bryan; Maria Francisca Garcia-Saura; Selena Bauer; David R Whitlock; Peter C Ford; David R Janero; Juan Rodriguez; Houman Ashrafian Journal: J Biol Chem Date: 2008-10-03 Impact factor: 5.157
Authors: Matthias Totzeck; Ulrike B Hendgen-Cotta; Peter Luedike; Michael Berenbrink; Johann P Klare; Heinz-Juergen Steinhoff; Dominik Semmler; Sruti Shiva; Daryl Williams; Anja Kipar; Mark T Gladwin; Juergen Schrader; Malte Kelm; Andrew R Cossins; Tienush Rassaf Journal: Circulation Date: 2012-06-09 Impact factor: 29.690
Authors: Edward A Pankey; Adeleke M Badejo; David B Casey; George F Lasker; Russel A Riehl; Subramanyam N Murthy; Bobby D Nossaman; Philip J Kadowitz Journal: Nitric Oxide Date: 2012-03-14 Impact factor: 4.427
Authors: Jason D Allen; Thomas Stabler; Aarti Kenjale; Katherine L Ham; Jennifer L Robbins; Brian D Duscha; Devon A Dobrosielski; Brian H Annex Journal: Free Radic Biol Med Date: 2010-07-08 Impact factor: 7.376
Authors: Edite Figueiras; Ricardo Oliveira; Cátia F Lourenço; Rita Campos; Anne Humeau-Heurtier; Rui M Barbosa; João Laranjinha; Luis F Requicha Ferreira; Frits F M de Mul Journal: Med Biol Eng Comput Date: 2012-10-12 Impact factor: 2.602
Authors: Jason D Allen; Thomas Stabler; Aarti A Kenjale; Katherine L Ham; Jennifer L Robbins; Brian D Duscha; William E Kraus; Brian H Annex Journal: J Diabetes Complications Date: 2013-12-17 Impact factor: 2.852